ClinicalTrials HQ

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Recruiting · NCT07003100 · Registry updated 2026-09-14
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care MogamulizumabHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Sezary syndrome, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphomaRecruitingNot stated2026-09-14NCT07003100

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
City of Hope Medical Center347
National Cancer Institute (NCI)3015

10 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Brigham and Women's HospitalBostonUnited States511
City of Hope Medical CenterDuarteUnited States313
Emory University Hospital/Winship Cancer InstituteAtlantaUnited States299
Fred Hutchinson Cancer CenterSeattleUnited States250
Johns Hopkins University/Sidney Kimmel Cancer CenterBaltimoreUnited States238
M D Anderson Cancer CenterHoustonUnited States667
Moffitt Cancer CenterTampaUnited States523
Siteman Cancer Center at Washington UniversitySt LouisUnited States10
Stanford Cancer Institute Palo AltoPalo AltoUnited States122
Thomas Jefferson University HospitalPhiladelphiaUnited States271